Israel’s EarlySense Gets Approval to Distrubte in Korea

EarlySense, an Israeli company which develops contact free monitoring solutions for the ill, received approval to distribute its system including, the Bedside Monitor and Central Display System, in the More...

Pluristem’s Phase I/II Muscle Injury Trial Successfully Meets Primary Safety & Efficacy Endpoints

Pluristem Therapeutics Inc. (NasdaqCM: PSTI; TASE: PLTR), a leading developer of placenta-based cell therapies, today announced top-line results from its Phase I/II clinical trial testing the safety More...